Suscribirse

The detection rate of granulomas differs between intestinal segments and lesions in Chinese patients with Crohn's disease - 02/02/23

Doi : 10.1016/j.clinre.2023.102076 
Lin-Teng Chen a, Jin-Yan Zhang a, b, Jian-Wei Zheng b, Juan Yu b, Yi Ding c, Wei-Lin Yang d, Hua Li a, b, , Wei-Feng Huang a, b,
a The School of Clinical Medicine, Fujian Medical University, Fuzhou, China 
b Department of Gastroenterology, The First Affiliated Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen, China 
c Department of Pathology, The First Affiliated Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen, China 
d Endoscopy center, The First Affiliated Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen, China 

Corresponding author at: The School of Clinical Medicine, Fujian Medical University, Fuzhou, China.The School of Clinical Medicine, Fujian Medical UniversityFuzhouChina⁎⁎Corresponding author at: The School of Clinical Medicine, Fujian Medical University, Fuzhou, China.The School of Clinical Medicine, Fujian Medical UniversityFuzhouChina

Highlights

What is already known on this subject?
Non-caseating granulomas are a hallmark histologic finding for the diagnosis of Crohn's disease. But the detection rate of granulomas at endoscopy was low.
What are the new findings?
The detection rate of granulomas differs between intestinal segments and lesions in patients with Crohn's disease.
How might it impact on clinical practice in the foreseeable future?
The research may help to improve the detection rate of granulomas in clinical practice.

El texto completo de este artículo está disponible en PDF.

Abstract

Background

Crohn's disease (CD) is characterized by non-caseating intestinal granulomas. However, the reported detection rate of granulomas on endoscopy is low. This study aimed to analyze the differences in the detection rate of granulomas in different intestinal segments and lesions in Chinese patients with CD to improve the detection rate of granulomas in clinical practice.

Patients and methods

113 patients with CD were analyzed retrospectively. Patients were divided into two groups: those with (n = 51) and without granulomas (n = 62) on endoscopic biopsies. Clinical information was collected from the medical records, including age; erythrocyte sedimentation rate (ESR); C-reactive protein (CRP), albumin, and hemoglobin (Hb) levels; platelet count; disease course; sex; smoking history; related operation history; Montreal classification; and lesion location, size, and shape.

Results

The detection rates of granulomas in different lesion shapes were significantly different (P < 0.001), with those of longitudinal ulcers and circular ulcers being higher than those of erosion and irregular ulcers. We also found that the detection rates of granulomas in ascending colon and sigmoid colon were relatively higher than other segments of the intestine, however, the difference was not statistically significant (P = 0.716). Additionally, age, sex, smoking history, Montreal classification, related surgical history, disease course, and serum biochemical indicators (ESR; platelet count; and CRP, albumin, and Hb levels) were not significantly different between the two groups.

Conclusions

The detection rate of granulomas in patients with CD is related to the morphology of the intestinal lesions. Meanwhile, lesion location may be correlated with the detection rate of granulomas.

El texto completo de este artículo está disponible en PDF.

Keywords : Granuloma, Detection rate, Crohn's disease, Endoscopic biopsy, Ulcer


Esquema


© 2023  Elsevier Masson SAS. Reservados todos los derechos.
Añadir a mi biblioteca Eliminar de mi biblioteca Imprimir
Exportación

    Exportación citas

  • Fichero

  • Contenido

Vol 47 - N° 2

Artículo 102076- février 2023 Regresar al número
Artículo precedente Artículo precedente
  • Clinical application study on miR-98–5p as a prognostic biomarker in hepatocellular carcinoma
  • Peng-tian Ji, Xiao-yan Wang
| Artículo siguiente Artículo siguiente
  • Drug-induced hepatitis (DIH) after SARS-CoV-2 vaccination
  • Ali Asgarzdeh, Shahram Habibzadeh, Vahid Asghariazar, Elham Safarzadeh

Bienvenido a EM-consulte, la referencia de los profesionales de la salud.
El acceso al texto completo de este artículo requiere una suscripción.

¿Ya suscrito a @@106933@@ revista ?

@@150455@@ Voir plus

Mi cuenta


Declaración CNIL

EM-CONSULTE.COM se declara a la CNIL, la declaración N º 1286925.

En virtud de la Ley N º 78-17 del 6 de enero de 1978, relativa a las computadoras, archivos y libertades, usted tiene el derecho de oposición (art.26 de la ley), el acceso (art.34 a 38 Ley), y correcta (artículo 36 de la ley) los datos que le conciernen. Por lo tanto, usted puede pedir que se corrija, complementado, clarificado, actualizado o suprimido información sobre usted que son inexactos, incompletos, engañosos, obsoletos o cuya recogida o de conservación o uso está prohibido.
La información personal sobre los visitantes de nuestro sitio, incluyendo su identidad, son confidenciales.
El jefe del sitio en el honor se compromete a respetar la confidencialidad de los requisitos legales aplicables en Francia y no de revelar dicha información a terceros.


Todo el contenido en este sitio: Copyright © 2026 Elsevier, sus licenciantes y colaboradores. Se reservan todos los derechos, incluidos los de minería de texto y datos, entrenamiento de IA y tecnologías similares. Para todo el contenido de acceso abierto, se aplican los términos de licencia de Creative Commons.